Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Decision

Decision

Prioritisation programme

Prioritisation programme

Showing 21 to 30 of 389

Topic prioritisation
TitlePrioritisation programmeDecisionDecision date
Ciclosporin (Vevizye) eye drops for treating moderate to severe keratoconjunctivitis [TSID12293]Medicines evaluationNot selected
Subcutaneous olanzapine for treating schizophrenia [TSID12289]Medicines evaluationNot selected
Menotrophin prefilled pen for treating anovulation or during controlled ovarian hyperstimulation [TSID12290]Medicines evaluationNot selected
Xeomin (botulinum neurotoxin type A) for treating lower or upper limb spasticity in people 2 to 17 years [TSID12297]None selectedNot selected
Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331]None selectedAwaiting decision
Epcoritamab + R-CHOP for Diffuse large B-cell lymphoma (DLBCL) [TSID12334]None selectedAwaiting decision
Lanadelumab for preventing recurrent attacks of hereditary angioedema in people 2 years and over [TSID12298]None selectedNot selected
Ivacaftor–tezacaftor–elaxcaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in people 1 to under 2 years [TSID12295]None selectedNot selected
Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more responsive mutations in the CFTR gene in people 2 to 5 years [TSID12296]None selectedNot selected
Thermal Probe Ablation for abdominal wall endometriosisNone selectedAwaiting decision

Results per page

  1. 10
  2. 25
  3. 50
  4. All